DE2647094B1 - Verfahren zur Herstellung von hochreinem S-Carboxymethyl-L-cystein - Google Patents
Verfahren zur Herstellung von hochreinem S-Carboxymethyl-L-cysteinInfo
- Publication number
- DE2647094B1 DE2647094B1 DE2647094A DE2647094A DE2647094B1 DE 2647094 B1 DE2647094 B1 DE 2647094B1 DE 2647094 A DE2647094 A DE 2647094A DE 2647094 A DE2647094 A DE 2647094A DE 2647094 B1 DE2647094 B1 DE 2647094B1
- Authority
- DE
- Germany
- Prior art keywords
- cysteine
- carboxymethyl
- reaction
- acid
- cystine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 9
- 238000004519 manufacturing process Methods 0.000 title description 3
- GBFLZEXEOZUWRN-VKHMYHEASA-N S-carboxymethyl-L-cysteine Chemical compound OC(=O)[C@@H](N)CSCC(O)=O GBFLZEXEOZUWRN-VKHMYHEASA-N 0.000 title 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 16
- 238000006243 chemical reaction Methods 0.000 claims description 15
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 14
- GBFLZEXEOZUWRN-VKHMYHEASA-M S-carboxylatomethyl-L-cysteine(1-) Chemical compound [O-]C(=O)[C@@H]([NH3+])CSCC([O-])=O GBFLZEXEOZUWRN-VKHMYHEASA-M 0.000 claims description 14
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 claims description 12
- 229940106681 chloroacetic acid Drugs 0.000 claims description 12
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 8
- 229910052708 sodium Inorganic materials 0.000 claims description 8
- 239000004201 L-cysteine Substances 0.000 claims description 7
- 235000013878 L-cysteine Nutrition 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 229910021529 ammonia Inorganic materials 0.000 claims description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 4
- 150000001447 alkali salts Chemical class 0.000 claims description 4
- 235000019253 formic acid Nutrition 0.000 claims description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 239000011593 sulfur Substances 0.000 claims description 3
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 238000001704 evaporation Methods 0.000 claims description 2
- 230000008020 evaporation Effects 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 230000020477 pH reduction Effects 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 13
- 229960003067 cystine Drugs 0.000 description 13
- 239000004158 L-cystine Substances 0.000 description 12
- 235000019393 L-cystine Nutrition 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- HRKQOINLCJTGBK-UHFFFAOYSA-N dihydroxidosulfur Chemical class OSO HRKQOINLCJTGBK-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- SAEXFNRQXFBCIC-NVKWYWNSSA-L disodium;(2r)-2-amino-3-sulfanylpropanoate Chemical compound [Na+].[Na+].SC[C@H](N)C([O-])=O.SC[C@H](N)C([O-])=O SAEXFNRQXFBCIC-NVKWYWNSSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000004715 keto acids Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2647094A DE2647094B1 (de) | 1976-10-19 | 1976-10-19 | Verfahren zur Herstellung von hochreinem S-Carboxymethyl-L-cystein |
| NL7708981A NL7708981A (nl) | 1976-10-19 | 1977-08-15 | Werkwijze ter bereiding van zeer zuiver s-carbo- xymethyl-l-cysteine. |
| US05/833,043 US4129593A (en) | 1976-10-19 | 1977-09-14 | Process for the production of high purity S-carboxymethyl-L-cysteine |
| FR7728567A FR2371423A1 (fr) | 1976-10-19 | 1977-09-22 | Procede de preparation d'une s-carboxymethyl-l-cysteine de haute purete |
| GB42819/77A GB1532940A (en) | 1976-10-19 | 1977-10-14 | Process for the production of highly pure s-carboxymethyl-l-cysteine |
| CH1269777A CH628618A5 (de) | 1976-10-19 | 1977-10-18 | Verfahren zur herstellung von hochreinem s-carboxymethyl-l-cystein. |
| BE6046183A BE859870A (fr) | 1976-10-19 | 1977-10-18 | Procede pour la preparation de s-carboxymethyl-l-cysteine de haute purete et produits obtenus |
| JP12503777A JPS5350118A (en) | 1976-10-19 | 1977-10-18 | Method of manufacturing high purity sscarboxymethyllllcysteine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2647094A DE2647094B1 (de) | 1976-10-19 | 1976-10-19 | Verfahren zur Herstellung von hochreinem S-Carboxymethyl-L-cystein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2647094B1 true DE2647094B1 (de) | 1978-04-13 |
| DE2647094C2 DE2647094C2 (enExample) | 1979-02-08 |
Family
ID=5990806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2647094A Granted DE2647094B1 (de) | 1976-10-19 | 1976-10-19 | Verfahren zur Herstellung von hochreinem S-Carboxymethyl-L-cystein |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4129593A (enExample) |
| JP (1) | JPS5350118A (enExample) |
| BE (1) | BE859870A (enExample) |
| CH (1) | CH628618A5 (enExample) |
| DE (1) | DE2647094B1 (enExample) |
| FR (1) | FR2371423A1 (enExample) |
| GB (1) | GB1532940A (enExample) |
| NL (1) | NL7708981A (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105418471B (zh) * | 2015-12-24 | 2017-09-05 | 宜昌三峡制药有限公司 | 一种羧甲司坦的合成方法 |
| CN106083673B (zh) * | 2016-06-29 | 2017-11-03 | 罗江晨明生物制品有限公司 | 一种羧甲司坦的制备工艺 |
| CN110563596B (zh) * | 2019-09-16 | 2022-07-26 | 山东泰和水处理科技股份有限公司 | 一种二羧甲基氨基酸盐的制备方法 |
| CN111138326A (zh) * | 2019-12-31 | 2020-05-12 | 宁波市远发生物工程有限公司 | 一种s-羧甲基-l-半胱氨酸的制备方法 |
| CN115557864B (zh) * | 2021-07-01 | 2024-06-18 | 广东众生药业股份有限公司 | 一种羧甲司坦的工业化制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2460785A (en) * | 1946-03-14 | 1949-02-01 | Merck & Co Inc | Processes for preparing substituted propanoic acid |
| US3184505A (en) * | 1962-06-18 | 1965-05-18 | Mead Johnson & Co | Process for the n-monoacylation of cysteine |
-
1976
- 1976-10-19 DE DE2647094A patent/DE2647094B1/de active Granted
-
1977
- 1977-08-15 NL NL7708981A patent/NL7708981A/xx not_active Application Discontinuation
- 1977-09-14 US US05/833,043 patent/US4129593A/en not_active Expired - Lifetime
- 1977-09-22 FR FR7728567A patent/FR2371423A1/fr active Granted
- 1977-10-14 GB GB42819/77A patent/GB1532940A/en not_active Expired
- 1977-10-18 JP JP12503777A patent/JPS5350118A/ja active Granted
- 1977-10-18 CH CH1269777A patent/CH628618A5/de not_active IP Right Cessation
- 1977-10-18 BE BE6046183A patent/BE859870A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2371423B1 (enExample) | 1980-08-29 |
| NL7708981A (nl) | 1978-04-21 |
| BE859870A (fr) | 1978-04-18 |
| FR2371423A1 (fr) | 1978-06-16 |
| DE2647094C2 (enExample) | 1979-02-08 |
| US4129593A (en) | 1978-12-12 |
| CH628618A5 (de) | 1982-03-15 |
| GB1532940A (en) | 1978-11-22 |
| JPS5542987B2 (enExample) | 1980-11-04 |
| JPS5350118A (en) | 1978-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2647094B1 (de) | Verfahren zur Herstellung von hochreinem S-Carboxymethyl-L-cystein | |
| EP0417604B1 (de) | Verfahren zur Herstellung von Riboflavin-5'-phosphat bzw. dessen Natriumsalz | |
| DE2647094C3 (enExample) | ||
| DE4021274A1 (de) | Verfahren zur reinigung von fermentativ hergestelltem riboflavin | |
| DE3538746C2 (enExample) | ||
| DE69505613T2 (de) | Synthese von Mercaptocarbonsäureestern | |
| DE3638364A1 (de) | Verfahren zur herstellung von 5-aminosalicylsaeure | |
| DE2118493C3 (de) | Verfahren zur Herstellung von Aminostilbenen | |
| DE2244652C3 (de) | Verfahren zur Herstellung von 2,3-Dicyan-1,4-dithiaanthrahydrochinon und -anthrachinon | |
| EP0039812B1 (de) | Verfahren zur Herstellung von 3-Hydroxybenzoesäure | |
| DE610926C (de) | Verfahren zur Herstellung von Aminoalkylsulfonsaeuren | |
| DE2509481C3 (de) | Verfahren zur Herstellung von N-Acetylsalicylamid | |
| CH620903A5 (enExample) | ||
| DE742254C (de) | Verfahren zur Darstellung von nahezu wasserfreiem und sehr reinem Natriumsulfid | |
| DD204915B1 (de) | Verfahren zur herstellung von reinem n-(4-(beta- geschweifte klammer auf 2-methoxy-5-chlor-benzamido geschweifte klammer zu -aethyl)-phenylsulfonyl)-n'-cyclohexylharnstoff | |
| DE2503921C2 (de) | Verfahren zur Gewinnung von D,L- Homocystein | |
| DE398309C (de) | Verfahren zur Herstellung von Anthranol | |
| DE870276C (de) | Verfahren zur Herstellung eines Doppelsalzes der p-Amino-salicylsaeure | |
| AT239243B (de) | Verfahren zur Herstellung von 2, 3-Dicyan-1, 4-dithia-anthrahydrochinon und -anthrachinon | |
| DE1222049B (de) | Verfahren zur Herstellung von 1, 2, 5, 6, 9, 10-Hexabromcyclododecan | |
| DE907898C (de) | Verfahren zur Herstellung von Cholinabkoemmlingen | |
| DE1593878C (de) | Verfahren zur Herstellung von Chlorthiophenolen | |
| CH548402A (de) | Verfahren zur herstellung von 3-methoxy-2-sulfanilamidopyrazin. | |
| CH341833A (de) | Verfahren zur Herstellung von 2,4,5-Trichlor-phenoxyessigsäure | |
| CH313553A (de) | Verfahren zur Herstellung von Thioätherdicarbonsäuren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8339 | Ceased/non-payment of the annual fee |